MCI
MRNA icon

MRP Capital Investments’s Moderna MRNA Stock Holding History

MRP Capital Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50
Closed -$1.38K – 212
2025
Q2 		$1.38K Buy
+50
New +$1.32K ﹤0.01% 179
2025
Q1 		– Sell
-50
Closed -$2.08K – 226
2024
Q4 		$2.08K Buy
+50
New +$2.39K ﹤0.01% 205
2023
Q3 		– Sell
-50
Closed -$6.08K – 165
2023
Q2 		$6.08K Sell
50
-3,610
-99% -$482K 0.01% 212
2023
Q1 		$562K Sell
3,660
-1,060
-22% -$175K 0.62% 58
2022
Q4 		$848K Buy
+4,720
New +$772K 0.94% 34

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MRP Capital Investments's MRNA Position: Q3 2025 in Review

MRP Capital Investments sold out of Moderna (MRNA) in Q3 2025, closing a stake of 50 shares — an estimated $1.38K sold.

MRP Capital Investments first reported a position in MRNA in Q4 2022 and held it in 5 quarters. The position peaked at $848K in Q4 2022. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • MRP Capital Investments reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • MRP Capital Investments sold 50 Moderna shares in Q3 2025, an estimated $1.38K.
  • MRP Capital Investments first reported a position in Moderna in Q4 2022 and held it in 5 quarters.
  • MRP Capital Investments's Moderna position peaked at $848K in Q4 2022.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on MRP Capital Investments's 13F filing for Q3 2025, filed 7 Nov 2025.